Glaukos (GKOS) Debt Ratio (2014 - 2021)

Glaukos' (GKOS) quarterly Debt Ratio came in at 0.27 in Q2 2021, down 1.89% on a QoQ basis from 0.27 in Q1 2021.

Glaukos (GKOS) Debt Ratio (2014 - 2021) Analysis & Trends

Glaukos (GKOS) has 5 years of Debt Ratio data on file, last reported at 0.27 in Q2 2021.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.27 in Q2 2021; TTM through Jun 2021 was 0.27, a N/A change from a year earlier, with the FY2020 full-year figure at 0.09, changed N/A from the prior year.
Debt Ratio for Q2 2021 stood at 0.27, down from 0.27 in the prior quarter.
Over the last five years, Debt Ratio for GKOS reached as high as 0.27 in Q1 2021 and fell as low as 0.09 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	Glaukos	8.83 Bn	8.73 Bn	117.23 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	0.27
Mar 31, 2021	0.27
Dec 31, 2020	0.09
Sep 30, 2016	0.02
Jun 30, 2016	0.04
Mar 31, 2016	0.06
Dec 31, 2015	0.08
Sep 30, 2015	0.10
Jun 30, 2015	0.16
Dec 31, 2014	0.67